Skip to main content
Genmab A/S (CPH: GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,483.50
+36.00 (2.49%)
Nov 22, 2024, 4:59 PM CET

Genmab Market Cap

Genmab has a market cap or net worth of 94.22 billion as of November 22, 2024. Its market cap has decreased by -33.77% in one year.

Market Cap
94.22B
Enterprise Value
77.89B
Revenue
19.84B
Ranking
n/a
PE Ratio
20.54
Stock Price
1,483.50

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 94.22B, an increase of 2,457.47%. That is a compound annual growth rate of 14.39%.

History

DateMarket Cap% Change
Nov 21, 202491.94B-34.69%
Dec 29, 2023140.77B-26.77%
Dec 30, 2022192.23B11.72%
Dec 30, 2021172.06B6.80%
Dec 30, 2020161.11B67.11%
Dec 30, 201996.41B46.85%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Novo Nordisk A/S 3,322.52B
Coloplast A/S 200.73B
Demant A/S 57.95B
Zealand Pharma A/S 51.33B
H. Lundbeck A/S 43.25B
H. Lundbeck A/S 43.25B
ALK-Abelló A/S 35.06B
Ambu A/S 30.36B
Market Cap Rankings